FDA clearance of the OneRF device for trigeminal neuralgia marks the company’s first expansion into the treatment of chronic pain. NeuroOne also sells its FDA-cleared OneRF sEEG brain ablation system ...

Kriya is advancing a host of gene therapies for a wide variety of chronic diseases, including geographic atrophy, trigeminal ...

NeuroOne Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its OneRF ...

In this week’s edition of InnovationRx, we look at Phil Knight’s big cancer gift, Medallion’s credentialing clearinghouse, a ...

Trigeminal nerve ablation, a minimally invasive procedure, uses RF energy to destroy abnormal tissue and relieve severe, ...

Gene therapy biotech Kriya Therapeutics has secured $313 million in a new series fundraise. | Gene therapy biotech Kriya ...

Trigeminal neuralgia is only one part of the actor’s medical profile. A brain aneurysm — a potentially life-threatening condition if it ruptures — and AVM, a rare defect in the blood vessels ...

Good day, ladies and gentlemen. Welcome to the Third Quarter of Fiscal Year 2025 and financial results conference Call for NeuroOne Medical Technologies Corporation. Today’s call will […] ...

Technologies has received U.S. Food and Drug Administration, FDA, clearance to market its OneRF Trigeminal Nerve Ablation ...

Neuroone Medical Technologies Corp. expanded into treatment of chronic pain with a new U.S. FDA clearance for use of its Onerf system to treat trigeminal nerve pain. The system uses radiofrequency ...

Marsha Garcia, founder of TN Warrior Racing, shares her journey of racing and advocacy for those suffering from chronic pain, ...